NEWS
Our Latest News
ARCHIMED Pharma Services announces the spin-off of portfolio company Suanfarma’s subsidiary, SuanNutra
The corporate carve-out is part of Suanfarma’s strategy to aggressively build its core business in the active pharmaceutical ingredient market. SuanNutra, which accounts for approximately a quarter of Suanfarma’s sales, is a scalable, globally recognized leader in the nutraceutical ingredients sector.
ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices
September
11,
2024
ARCHIMED buys Cellese, a pioneering developer of growth factors and exosome-based skincare products
September
4,
2024
ARCHIMED acquires Irrimax, market leader in anti-microbial wound irrigation solutions
August
28,
2024
368